{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:59:39Z","timestamp":1773392379981,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study describes the efficacy of a new protamine zinc recombinant human insulin (PZIR) preparation for treating diabetic cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate effects of PZIR on control of glycemia in cats with newly diagnosed or poorly controlled diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>One hundred and thirty-three diabetic cats 120 newly diagnosed and 13 previously treated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective, uncontrolled clinical trial. Cats were treated with PZIR twice daily for 45 days. Control of glycemia was assessed on days 7, 14, 30, and 45 by evaluation of change in water consumption, frequency of urination, appetite, and body weight, serum fructosamine concentration, and blood glucose concentrations determined 1, 3, 5, 7, and 9 hours after administration of PZIR. Adjustments in dosage of PZIR were made as needed to control glycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PZIR administration resulted in a significant decrease in 9-hour mean blood glucose (199 \u00b1 114 versus 417 \u00b1 83\u2003mg\/dL, X\u00b1 SD, P &amp;lt; .001) and serum fructosamine (375 \u00b1 117 versus 505 \u00b1 96\u2003\u03bcmol\/L, P &amp;lt; .001) concentration and a significant increase in mean body weight (5.9 \u00b1 1.4 versus 5.4 \u00b1 1.5\u2003kg, P= .017) in 133 diabetic cats at day 45 compared with day 0, respectively. By day 45, polyuria and polydipsia had improved in 79% (105 of 133), 89% (118 of 133) had a good body condition, and 9-hour mean blood glucose concentration, serum fructosamine concentration, or both had improved in 84% (112 of 133) of the cats compared with day 0. Hypoglycemia (&amp;lt;80\u2003mg\/dL) was identified in 151 of 678, 9-hour serial blood glucose determinations and in 85 of 133 diabetic cats. Hypoglycemia causing clinical signs was confirmed in 2 diabetic cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Relevance<\/jats:title>\n                    <jats:p>PZIR is effective for controlling glycemia in diabetic cats and can be used as an initial treatment or as an alternative treatment in diabetic cats that do not respond to treatment with other insulin preparations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2009.0342.x","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T10:17:28Z","timestamp":1246011448000},"page":"787-793","source":"Crossref","is-referenced-by-count":28,"title":["Field Safety and Efficacy of Protamine Zinc Recombinant Human Insulin for Treatment of Diabetes Mellitus in Cats"],"prefix":"10.1093","volume":"23","author":[{"name":"the PZIR Clinical Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Nelson","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California Department of Medicine and Epidemiology, , Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Henley","sequence":"additional","affiliation":[{"name":"IDEXX Pharmaceuticals Inc , Greensboro, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cole","sequence":"additional","affiliation":[{"name":"IDEXX Pharmaceuticals Inc , Greensboro, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"2026020303105294300_b1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2460\/javma.1983.182.02.158","article-title":"Insulin therapy in cats with diabetes mellitus","volume":"182","author":"Moise","year":"1983","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b2","first-page":"548","article-title":"Diabetes mellitus in the cat","volume":"9","author":"Schaer","year":"1973","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303105294300_b3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2460\/javma.1995.206.11.1729","article-title":"Effect of lente insulin for treatment of diabetes mellitus in 12 cats","volume":"206","author":"Bertoy","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b4","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2460\/javma.1992.200.12.1828","article-title":"Use of ultralente insulin in cats with diabetes mellitus","volume":"200","author":"Nelson","year":"1992","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1998.tb00489.x","article-title":"Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985\u20131995)","volume":"12","author":"Goossens","year":"1998","journal-title":"J Vet Intern Med"},{"key":"2026020303105294300_b6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.2006.tb02851.x","article-title":"Use of glargine and lente insulins in cats with diabetes mellitus","volume":"20","author":"Weaver","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020303105294300_b7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2460\/javma.2001.218.38","article-title":"Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats","volume":"218","author":"Nelson","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b8","first-page":"247","article-title":"Analysis of risk to biomedical products developed from animal sources (with special emphasis on the spongiform encephalopathy agents, scrapie and BSE)","volume":"88","author":"Rohwer","year":"1996","journal-title":"Dev Biol Stand"},{"key":"2026020303105294300_b9","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2460\/javma.1999.214.12.1794","article-title":"Comparison of serum fructosamine and blood glycosylated hemoglobin concentration for assessment of glycemic control in cats with diabetes mellitus","volume":"214","author":"Elliot","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b10","first-page":"363","article-title":"Diabetes responsive to intravenous but not subcutaneous insulin","volume":"305","author":"Freidenberg","year":"1981","journal-title":"Effectiveness of aprotinin"},{"key":"2026020303105294300_b11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM198607173150302","article-title":"In search of the subcutaneous-insulin-resistance syndrome","volume":"315","author":"Schade","year":"1986","journal-title":"N Engl J Med"},{"key":"2026020303105294300_b12","first-page":"28","article-title":"Transient clinical diabetes mellitus in cats","volume":"13","author":"Nelson","year":"1999","journal-title":"10 cases (1989\u20131991)"},{"key":"2026020303105294300_b13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0739-7240(90)90008-N","article-title":"Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats","volume":"7","author":"Wallace","year":"1990","journal-title":"Domest Anim Endocrinol"},{"key":"2026020303105294300_b14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2460\/ajvr.1994.55.01.127","article-title":"Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats","volume":"55","author":"Broussard","year":"1994","journal-title":"Am J Vet Res"},{"key":"2026020303105294300_b15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2460\/javma.1986.188.12.1426","article-title":"Rebound hyperglycemia following overdosing of insulin in cats with diabetes mellitus","volume":"188","author":"McMillan","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2460\/javma.2000.216.1082","article-title":"Effect of dietary insoluble fiber on control of glycemia in cats with naturally acquired diabetes mellitus","volume":"216","author":"Nelson","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303105294300_b17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jfms.2005.08.004","article-title":"Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus","volume":"8","author":"Bennett","year":"2006","journal-title":"J Fel Med Surg"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2009.0342.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/4\/787\/66653812\/j.1939-1676.2009.0342.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/4\/787\/66653812\/j.1939-1676.2009.0342.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:11:06Z","timestamp":1770106266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/23\/4\/787\/8447177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0342.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,7]]},"published":{"date-parts":[[2009,7,1]]}}}